Literature DB >> 15986102

Multiple primary cancers of separate organ sites: implications for research and cancer control (Australia).

Adrian Heard1, David Roder, Colin Luke.   

Abstract

OBJECTIVE: To identify cancers which occur as second primaries following the diagnosis of cancers of other sites, as a basis for formulating causal hypotheses and planning medical surveillance.
METHODS: Analyses of fifteen common cancer sites were undertaken to examine the occurrence of multiple primaries. These cancers were notified to the South Australian Cancer Registry during 1977-2001. Historic cohort models were used where standardised incidence ratios (95 confidence limits) were calculated to indicate the risk of second primary cancers.
RESULTS: New associations detected included an increased risk of cancers of the bladder, colon, rectum, kidney and melanomas following a diagnosis of prostate cancer and an increased risk of leukaemia following both lung and rectal cancer. Many previously identified combinations of multiple primaries were confirmed.
CONCLUSIONS: From the wide range of associations identified, some such as leukaemias occurring as second primaries after the diagnosis of ovarian cancers and lymphomas may be a treatment effect. The diagnosis of multiple primary cancers in the same month (e.g. bladder-prostate cancers and ovarian-uterine cancers) may reflect patterns of medical testing and the long preclinical phases of some cancers.

Entities:  

Mesh:

Year:  2005        PMID: 15986102     DOI: 10.1007/s10552-004-8023-0

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  15 in total

1.  Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.

Authors:  Aung Ko Win; Noralane M Lindor; Joanne P Young; Finlay A Macrae; Graeme P Young; Elizabeth Williamson; Susan Parry; Jack Goldblatt; Lara Lipton; Ingrid Winship; Barbara Leggett; Katherine M Tucker; Graham G Giles; Daniel D Buchanan; Mark Clendenning; Christophe Rosty; Julie Arnold; A Joan Levine; Robert W Haile; Steven Gallinger; Loïc Le Marchand; Polly A Newcomb; John L Hopper; Mark A Jenkins
Journal:  J Natl Cancer Inst       Date:  2012-08-28       Impact factor: 13.506

2.  The risk of colorectal cancer is not increased after a diagnosis of urothelial cancer: a population-based study.

Authors:  C H Harlos; H Singh; Z Nugent; A Demers; S M Mahmud; P M Czaykowski
Journal:  Curr Oncol       Date:  2016-12-21       Impact factor: 3.677

3.  Metachronous double primary cancer after diagnosis of gastric cancer.

Authors:  Jin Young Kim; Won Young Jang; Mi Hwa Heo; Kang Kuk Lee; Young Rok Do; Keon Uk Park; Hong Suk Song; Yoon Nyun Kim
Journal:  Cancer Res Treat       Date:  2012-09-30       Impact factor: 4.679

4.  Bladder cancer in cancer patients: population-based estimates from a large Swedish study.

Authors:  J Lorenzo Bermejo; J Sundquist; K Hemminki
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

5.  Urothelial cancer and the diagnosis of subsequent malignancies.

Authors:  Deepak K Pruthi; Zoann Nugent; Piotr Czaykowski; Alain A Demers
Journal:  Can Urol Assoc J       Date:  2013 Jan-Feb       Impact factor: 1.862

6.  Multiple primary malignancies involving colorectal cancer--clinical characteristics and prognosis with reference to surveillance.

Authors:  Won-Suk Lee; Jung Nam Lee; Sangtae Choi; Min Jung; Jeong-Heum Baek; Woon Kee Lee
Journal:  Langenbecks Arch Surg       Date:  2009-09-09       Impact factor: 3.445

7.  Double primary malignancy in colorectal cancer patients--MSI is the useful marker for predicting double primary tumors.

Authors:  H R Yun; L J Yi; Y K Cho; J H Park; Y B Cho; S H Yun; H C Kim; H K Chun; W Y Lee
Journal:  Int J Colorectal Dis       Date:  2008-09-17       Impact factor: 2.571

8.  Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia.

Authors:  Iona Cheng; Jonathan M Kocarnik; Logan Dumitrescu; Noralane M Lindor; Jenny Chang-Claude; Christy L Avery; Christian P Caberto; Shelly-Ann Love; Martha L Slattery; Andrew T Chan; John A Baron; Lucia A Hindorff; Sungshim Lani Park; Fredrick R Schumacher; Michael Hoffmeister; Peter Kraft; Anne M Butler; David J Duggan; Lifang Hou; Chris S Carlson; Kristine R Monroe; Yi Lin; Cara L Carty; Sue Mann; Jing Ma; Edward L Giovannucci; Charles S Fuchs; Polly A Newcomb; Mark A Jenkins; John L Hopper; Robert W Haile; David V Conti; Peter T Campbell; John D Potter; Bette J Caan; Robert E Schoen; Richard B Hayes; Stephen J Chanock; Sonja I Berndt; Sebastien Küry; Stephane Bézieau; Jose Luis Ambite; Gowri Kumaraguruparan; Danielle M Richardson; Robert J Goodloe; Holli H Dilks; Paxton Baker; Brent W Zanke; Mathieu Lemire; Steven Gallinger; Li Hsu; Shuo Jiao; Tabitha A Harrison; Daniela Seminara; Christopher A Haiman; Charles Kooperberg; Lynne R Wilkens; Carolyn M Hutter; Emily White; Dana C Crawford; Gerardo Heiss; Thomas J Hudson; Hermann Brenner; William S Bush; Graham Casey; Loïc Le Marchand; Ulrike Peters
Journal:  Gut       Date:  2013-08-09       Impact factor: 23.059

9.  The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study.

Authors:  Danny R Youlden; Peter D Baade
Journal:  BMC Cancer       Date:  2011-02-23       Impact factor: 4.430

10.  Identifying related cancer types based on their incidence among people with multiple cancers.

Authors:  Chris D Bajdik; Zenaida U Abanto; John J Spinelli; Angela Brooks-Wilson; Richard P Gallagher
Journal:  Emerg Themes Epidemiol       Date:  2006-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.